TG Therapeutics, Inc. (TGTX) Financials

Key financial figures for TG Therapeutics, Inc. (Q2 2026).

Revenue

$240M

Net Income

$8M

EPS

$0.05

Total Assets

$1.6B

Operating Cash Flow

$39M

Full income statement, balance sheet, and cash flow for TG Therapeutics, Inc. on SentiSense.